Optimal dosing of renin-angiotensin-aldosterone system blockers for renal protection: a solved issue?

Diabetologia. 2009 Jun;52(6):1217-8. doi: 10.1007/s00125-009-1328-5. Epub 2009 Mar 18.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Albuminuria / drug therapy
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / therapeutic use*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 1 / physiopathology
  • Diabetic Angiopathies / drug therapy*
  • Diabetic Nephropathies / drug therapy*
  • Glomerular Filtration Rate / drug effects
  • Humans
  • Lisinopril / administration & dosage
  • Lisinopril / pharmacology
  • Lisinopril / therapeutic use*
  • Renin-Angiotensin System / drug effects

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Lisinopril